Rezza G - Search Results

1

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients.

d'Arminio Monforte A, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, Angarano G, Colangeli V, De Luca A, Ippolito G, Caggese L, Soscia F, Filice G, Gritti F, Narciso P, Tirelli U, Moroni M. d'Arminio Monforte A, et al. Among authors: rezza g. AIDS. 2000 Mar 31;14(5):499-507. doi: 10.1097/00002030-200003310-00005. AIDS. 2000. PMID: 10780712 Clinical Trial.

2

Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.

Rezza G, Titti F, Pezzotti P, Sernicola L, Lo Caputo S, Angarano G, Lazzarin A, Sinicco A, Rossi GB, Verani P. Rezza G, et al. J Biol Regul Homeost Agents. 1992 Jan-Mar;6(1):15-20. J Biol Regul Homeost Agents. 1992. PMID: 1359736

3

Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals.

Mariotto AB, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Mariotto AB, et al. Among authors: rezza g. Am J Epidemiol. 1992 Feb 15;135(4):428-37. doi: 10.1093/oxfordjournals.aje.a116303. Am J Epidemiol. 1992. PMID: 1550094

4

Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS.

Pezzotti P, Rezza G, Lazzarin A, Angarano G, Sinicco A, Aiuti F, Zerboni R, Salassa B, Gafà S, Pristerà R, et al. Pezzotti P, et al. Among authors: rezza g. J Acquir Immune Defic Syndr (1988). 1992;5(7):745-7. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1613677 No abstract available.

5

Monitoring HIV trends in injecting drug users: an Italian experience.

Zaccarelli M, Rezza G, Girardi E, Puro V, Pezzotti P, Lelli V, Narciso P. Zaccarelli M, et al. Among authors: rezza g. AIDS. 1990 Oct;4(10):1007-10. doi: 10.1097/00002030-199010000-00010. AIDS. 1990. PMID: 2261114

6

The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters.

Rezza G, Lazzarin A, Angarano G, Sinicco A, Pristerà R, Ortona L, Barbanera M, Gafà S, Tirelli U, Salassa B, et al. Rezza G, et al. AIDS. 1989 Feb;3(2):87-90. doi: 10.1097/00002030-198902000-00006. AIDS. 1989. PMID: 2496724

7

Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 cases.

Vaccher E, Tirelli U, Lazzarin A, Rezza G, Malfitano A, Raise E, Carbone A, Contu L, Alessi E, Monfardini S. Vaccher E, et al. Among authors: rezza g. AIDS. 1989 May;3(5):321. AIDS. 1989. PMID: 2504238 No abstract available.

8

Risk of developing AIDS in newly seropositive intravenous drug abusers.

Rezza G, Lazzarin A, Angarano G, Sinicco A, Pristerà R, Ortona L, Barbanera M, Salassa B, Tirelli U, Aiuti F, et al. Rezza G, et al. J Infect Dis. 1989 Jun;159(6):1156. doi: 10.1093/infdis/159.6.1156. J Infect Dis. 1989. PMID: 2656884 Clinical Trial. No abstract available.

9

AIDS in Italy.

Rezza G, Ippolito G, Marasca G, Greco D. Rezza G, et al. Lancet. 1984 Sep 15;2(8403):642. doi: 10.1016/s0140-6736(84)90634-2. Lancet. 1984. PMID: 6147676 No abstract available.

10

Clinical staging system for AIDS patients.

Cozzi Lepri A, Pezzotti P, Phillips AN, Petrucci A, Rezza G. Cozzi Lepri A, et al. Among authors: rezza g. Lancet. 1995 Oct 21;346(8982):1103. doi: 10.1016/s0140-6736(95)91778-0. Lancet. 1995. PMID: 7564813 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters